Current Status of Clostridium difficile Infection Epidemiology
暂无分享,去创建一个
[1] C. Kelly,et al. Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.
[2] C. Record,et al. Incidence and origin of Clostridium difficile in neonates , 1984, Journal of clinical microbiology.
[3] H Humphreys,et al. Prevalence surveys of healthcare-associated infections: what do they tell us, if anything? , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] L. Peterson,et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.
[5] Mark Miller,et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] J. Cavanaugh,et al. Trends in Clostridium difficile Infection among Peripartum Women , 2010, Infection Control & Hospital Epidemiology.
[7] L. Peterson,et al. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] J. Gerberding,et al. Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. , 2005, MMWR. Morbidity and mortality weekly report.
[9] A. Goorhuis,et al. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[10] D. Anderson,et al. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals , 2011, Infection Control & Hospital Epidemiology.
[11] T. Horan,et al. Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control & Hospital Epidemiology.
[12] S. Vindigni,et al. Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.
[13] L. McDonald,et al. Clostridium difficile Infection Among Children With Cancer , 2011, The Pediatric infectious disease journal.
[14] Myrna Dyck,et al. Population-Based Surveillance of Clostridium difficile Infection in Manitoba, Canada, by Using Interim Surveillance Definitions , 2009, Infection Control & Hospital Epidemiology.
[15] C. Donskey,et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] T. Eckmanns,et al. Clostridium difficile Surveillance Trends, Saxony, Germany , 2008, Emerging infectious diseases.
[17] E. Kuijper,et al. Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] J. R. Scotti,et al. Available From , 1973 .
[19] B. Wren,et al. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. , 2008, Journal of medical microbiology.
[20] L. Mascola,et al. Increase in Clostridium difficile–related Mortality Rates, United States, 1999–2004 , 2007, Emerging infectious diseases.
[21] M. Samore,et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea , 1998, The Lancet.
[22] J. Pemán,et al. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes , 2006 .
[23] M. Quail,et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium , 2009, Genome Biology.
[24] L. McDonald,et al. Bench-to-bedside review: Clostridium difficile colitis , 2008, Critical care.
[25] R. Barton,et al. Clindamycin-associated colitis. A prospective study. , 1974, Annals of internal medicine.
[26] M. Wilcox,et al. A case-control study of community-associated Clostridium difficile infection. , 2008, The Journal of antimicrobial chemotherapy.
[27] K. Welch,et al. Evaluation of Hospital Room Assignment and Acquisition of Clostridium difficile Infection , 2011, Infection Control & Hospital Epidemiology.
[28] M. Owings,et al. Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.
[29] D. Gerding,et al. Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] Ellen Jo Baron,et al. Impact of Strain Type on Detection of Toxigenic Clostridium difficile: Comparison of Molecular Diagnostic and Enzyme Immunoassay Approaches , 2010, Journal of Clinical Microbiology.
[31] J. Bartlett,et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.
[32] M. Zilberberg. Clostridium difficile Infections among Hospitalized Children , 2010 .
[33] A. Charlett,et al. Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods , 2009, Journal of Clinical Microbiology.
[34] C. Gidengil,et al. Epidemiology and Risk Factors for Clostridium difficile Infection in Children , 2011, The Pediatric infectious disease journal.
[35] R. Campbell,et al. Clostridium difficile Infection in Ohio Hospitals and Nursing Homes During 2006 , 2009, Infection Control & Hospital Epidemiology.
[36] D. Gerding,et al. Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.
[37] J. Tokars,et al. Automated Surveillance of Clostridium difficile Infections Using BioSense , 2011, Infection Control & Hospital Epidemiology.
[38] Jiaquan Xu,et al. Deaths: preliminary data for 2008. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[39] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[40] W. Stamm,et al. Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.
[41] I. C. Hall,et al. INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .
[42] Jon Brazier,et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.
[43] L. McDonald,et al. Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.
[44] E. Kuijper,et al. Clostridium difficile infection in Europe: a hospital-based survey , 2011, The Lancet.